Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

427 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
DNA content flow cytometry as a prognostic factor for node-positive breast cancer. The role of multiparameter ploidy analysis and specimen sonication.
Witzig TE, Gonchoroff NJ, Therneau T, Gilbertson DT, Wold LE, Grant C, Grande J, Katzmann JA, Ahmann DL, Ingle JN. Witzig TE, et al. Among authors: ingle jn. Cancer. 1991 Oct 15;68(8):1781-8. doi: 10.1002/1097-0142(19911015)68:8<1781::aid-cncr2820680822>3.0.co;2-0. Cancer. 1991. PMID: 1913523 Clinical Trial.
Randomized trial to evaluate the addition of tamoxifen to cyclophosphamide, 5-fluorouracil, prednisone adjuvant therapy in premenopausal women with node-positive breast cancer.
Ingle JN, Everson LK, Wieand HS, Cullinan SA, Wold LE, Hagen JB, Martin JK, Krook JE, Fitzgibbons RG, Foley JF, et al. Ingle JN, et al. Cancer. 1989 Apr 1;63(7):1257-64. doi: 10.1002/1097-0142(19890401)63:7<1257::aid-cncr2820630705>3.0.co;2-x. Cancer. 1989. PMID: 2646004 Clinical Trial.
Patterns of tumor relapse following mastectomy and adjuvant systemic therapy in patients with axillary lymph node-positive breast cancer. Impact of clinical, histopathologic, and flow cytometric factors.
Pisansky TM, Ingle JN, Schaid DJ, Hass AC, Krook JE, Donohue JH, Witzig TE, Wold LE. Pisansky TM, et al. Among authors: ingle jn. Cancer. 1993 Aug 15;72(4):1247-60. doi: 10.1002/1097-0142(19930815)72:4<1247::aid-cncr2820720418>3.0.co;2-s. Cancer. 1993. PMID: 8339215 Clinical Trial.
Comparison of estrogen receptor determinations by a biochemical ligand-binding assay and immunohistochemical staining with monoclonal antibody ER1D5 in females with lymph node positive breast carcinoma entered on two prospective clinical trials.
Alberts SR, Ingle JN, Roche PR, Cha SS, Wold LE, Farr GH Jr, Krook JE, Wieand HS. Alberts SR, et al. Among authors: ingle jn. Cancer. 1996 Aug 15;78(4):764-72. doi: 10.1002/(SICI)1097-0142(19960815)78:4<764::AID-CNCR12>3.0.CO;2-T. Cancer. 1996. PMID: 8756370
427 results